QuiVad
My list

Home / Funds / Voleon Capital Management LP

Voleon Capital Management LP

The short positions this fund discloses today, across every market.

Follow

Open short positions, the heaviest first.
IssuerMarket% of capitalSinceFiling
B&M European Value Retail S.A.Germany0.79%April 20, 2026
Oryzon Genomics, S.A.Spain0.60%October 5, 2026
Tubacex, S.A.Spain0.60%October 30, 2026
Genuit Group plcGermany0.54%October 20, 2026
Atos GroupFrance0.50%October 21, 2026
Mips ABSweden0.50%October 21, 2026

Follow by RSS

Get the moves on Voleon Capital Management LP by mail, at most once a day.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

6,010 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publicationFiling
April 28, 2021GenSight Biologics S.A.France0.49%April 30, 2021
April 28, 2021Cell Impact AB (publ)Sweden0.00%
April 27, 2021Juventus Football Club SPAItaly0.50%
April 26, 2021Quantum GenomicsFrance0.99%June 14, 2021
April 26, 2021Cell Impact AB (publ)Sweden0.58%
April 26, 2021GenSight Biologics S.A.France0.50%April 30, 2021
April 26, 2021Solutions 30 SEFrance0.49%April 28, 2021
April 22, 2021Erytech PharmaFrance0.80%May 20, 2021
April 22, 2021Phaxiam TherapeuticsFrance0.80%May 20, 2021
April 20, 2021Eurotech SPAItaly1.26%
April 20, 2021BiophytisFrance0.91%June 18, 2021
April 20, 2021Cell Impact AB (publ)Sweden0.69%
April 19, 2021Eurotech SPAItaly1.34%
April 19, 2021BiophytisFrance0.83%June 18, 2021
April 19, 2021Metabolic ExplorerFrance0.48%April 21, 2021
April 16, 2021Erytech PharmaFrance0.71%May 20, 2021
April 16, 2021Phaxiam TherapeuticsFrance0.71%May 20, 2021
April 16, 2021Duro Felguera, S.A.Spain0.59%
April 16, 2021Immunovia AB (publ)Sweden0.00%
April 15, 2021Quantum GenomicsFrance1.08%June 14, 2021
April 15, 2021Cell Impact AB (publ)Sweden0.79%
April 15, 2021Metabolic ExplorerFrance0.51%April 21, 2021
April 14, 2021Cell Impact AB (publ)Sweden0.83%
April 14, 2021Duro Felguera, S.A.Spain0.69%
April 14, 2021Immunovia AB (publ)Sweden0.59%
April 13, 2021NavyaFrance0.95%August 3, 2021AMF
April 13, 2021Cell Impact AB (publ)Sweden0.91%
April 13, 2021Duro Felguera, S.A.Spain0.72%
April 13, 2021BiophytisFrance0.70%June 18, 2021
April 13, 2021Erytech PharmaFrance0.61%May 20, 2021
April 13, 2021Phaxiam TherapeuticsFrance0.61%May 20, 2021
April 13, 2021Metabolic ExplorerFrance0.49%April 15, 2021
April 13, 2021Solocal GroupFrance0.45%April 15, 2021
April 12, 2021NavyaFrance1.16%August 3, 2021AMF
April 12, 2021BiophytisFrance0.89%June 18, 2021
April 12, 2021Immunovia AB (publ)Sweden0.67%
April 9, 2021Metro Bank PLCUnited Kingdom0.59%
April 9, 2021Solutions 30 SEFrance0.50%April 28, 2021
April 8, 2021NavyaFrance1.39%August 3, 2021AMF
April 8, 2021BiophytisFrance0.97%June 18, 2021
April 8, 2021Erytech PharmaFrance0.50%May 20, 2021
April 8, 2021Phaxiam TherapeuticsFrance0.50%May 20, 2021
April 7, 2021Eurotech SPAItaly1.49%
April 7, 2021Cell Impact AB (publ)Sweden1.07%
April 7, 2021Solocal GroupFrance0.57%April 15, 2021
April 7, 20214D Pharma PLCUnited Kingdom0.42%
April 7, 2021Oncopeptides ABSweden0.00%
April 6, 2021Cell Impact AB (publ)Sweden1.10%
April 6, 2021Duro Felguera, S.A.Spain0.84%
April 6, 2021Immunovia AB (publ)Sweden0.70%

The AMF column opens the filing the fund itself lodged, on the regulator own site. Documents read for positions up to August 26, 2026.

Download 6,010 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats

The funds short on the same companies

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Voleon Capital Management LP, data as at October 30, 2026, https://www.quivad.com/detenteur/voleon-capital-management-lp?page=65